Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-023313

Chief Development Officer sold 7,218 shares at $1.50 ($10,853)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jalota Deepika Chief Development Officer 2024-09-11 Sale −7,218 $1.50 $10,853 118,283 D
Open-market sales · 7,218 sh · avg $1.50 · $10,853
Loading xslF345X05/form4-09122024_100948.xml…